Study Details

Prevelance, Treatment Patterns & Resource Use in Patients With Mixed Dyslipidemia Using Lipid Lowering Agents

Jonathan B. Brown, Prinicipal Investigator
Gregory A. Nichols, Co-Investigator

 This study is estimating the prevalence of mixed dyslipidemia (MD) in patients on statins/lipid-lowering therapy (LLP) and/or in high-risk patients including CHD, DM, metabolic syndrome, and those with multiple risk factors. It is also supplying population-based data on determinants of treatment of MD in all patients and in various risk groups and evaluating characteristics of patients with MD.
Funding source: Merck & Co., Inc.

Our Locations
Three Regions — One Mission
Each CHR site conducts professionally independent, public domain research and disseminates its findings in the scholarly literature and scientific community.

Northwest
 3800 N. Interstate
Portland, OR 97227      
503.335.2400

Hawaii
 711 Kapiolani Blvd.
Suite 200
Honolulu, HI 96813
101.222.2400 		Southeast
 3495 Piedmont Road, NE
Ten Piedmont Center,
Suite 205
Atlanta, GA 30305
202.555.1212

US Map

 
Kaiser Permanente